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Some 4-aryl-5,6-dihydro-6-(substituted phenyl)-4H-1,3-oxa-
zine-2-amine derivatives including  4-(4-methyl-1-naphthyl)-5,6-
dihydro-6-(substituted phenyl)-4H-1,3-oxazine-2-amines have been 
synthesised by hydroxyapatite catalyzed solvent-free cyclization of 
aryl chalcones and urea using microwave irradiation under solvent-
free condition. The yields of the oxazines were more than 85%.  
The synthesised oxazine amines have been characterized by their 
physical constants, analytical and spectroscopic data. 
Key words: Oxazine-2-amines, Enones, Hydroxyapatite, Solvent-
free synthesis. 
 
 
1.  INTRODUCTION 
 
The Oxazine or unsaturated oxazine derivatives are important bio-
active six membered heterocyclic compounds which possess one oxygen 
and one nitrogen atom [1, 2].  Depend upon the relative position of these 
tow atoms and the double bond, these molecule exists many isomeric 
structures such as 1, 2 or 1, 3 or 1, 4 oxazines [3]. These oxazines were 
medicinally important due to the presence of  oxygen, nitrogen 
heteroatoms along with a double bonds in their  structural moieties [4].  
The important medicinal activities of these oxazines are anti-bacterial, 
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anti-fungal [4-6], anti-plasmodial [7], anti-cancer [8], anti-depressants [9], 
cytotoxicity [10], anti-osteoplastic [11], anti- tumour [12], anti-oxidant 
[13],  anti-tuberculosis [14], anti-neoplastic[15], antagonists [16], anti-
inflammatory [17], anti-infectants [18], IKB kinase beta [19] and PTP-1B 
inhibition [20]. These oxazine derivatives were applied for improving the 
super resolution Microscope [21], synthesis of eosinophils [22], 
identification and separation of neutrophils [23]. Many oxazine 
derivatives were used as a dyes [24].  Now-a-days scientists, organic 
chemists are interested for solvent-free synthesis [4, 25, 26, 27].  
Numerous solvent assisted and solvent-free synthetic methods were 
available for synthesis of oxazine derivatives [28-31]. Hetero Diels-alder 
reaction [4], ring closure [32], Betti base induced condensation [27], 
Mannich type condensation-cyclization [5] and cyclization of chalcones 
[6]  were used for synthesis of oxazine derivatives. Verma et. al. have 
synthesised  some benzoxazine/oxazine fused isoquinolines and 
naphthyridines by solvent-free method [5].  Elarfi  and Al-difar  have  
synthesised some 1, 3-oxazine derivatives  by solvent-assisted method 
from chalcones and urea[6].  More than 75% yield of dihydro-2H-benzo- 
and naphtho-1, 3-oxazine derivatives were prepared by Mathew et al.[5] 
using eco-friendly method. Efficient synthesis of some 1, 3-oxazine-4-
thiones  were synthesised by N-methyl imidazole promoted solvent-free 
conditions.  Sapkal et al., have studied the role of ammonium acetate for 
solvent-free synthesis of 1,3-disubstituted-2,3-dihydro-1H-naphyl 
oxazines [27]. Within the above view, there is no information available in 
the literature for the solvent-free synthesis of 4-aryl-5,6-dihydro-6-
(substituted phenyl)-4H-1,3-oxazine-2-amines derivatives including 4-(4-
methyl-1-naphthyl)-6-(substituted phenyl)-4H-1, 3-oxazine-2-amines  by 
cyclization of enones. Therefore the author have taken effort to synthesize 
some aryl oxazines including 4-(4-methyl-1-naphthyl)-6-(substituted 
phenyl) 4H-1,3-oxazine-2-amines  by cyclization of enones  under 
solvent-free conditions.  
 
 
2.  EXPERIMENTAL 
 
2.1. General 
All chemicals were used in this study were purchased from Sigma-
Aldrich and Merck Chemical companies.  Mettler FP51 melting point 
apparatus was used for determining the melting point of all synthesized 
oxazine-2-amines in open glass capillaries and are uncorrected. The 
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AVATAR-300 Fourier transform spectrophotometer was used for 
recording infrared spectra (KBr, 4000-400 cm–1) of all oxazines in KBr 
disc. The Bruker AV400 series type NMR spectrometer was utilized for 
recording NMR spectra of all oxazines, operating at 400MHz for 1H 
and 100 MHz for 13C spectra in CDCl3 solvent using TMS as internal 
standard. Mass spectra of all synthesised oxazines were recorded on 
SHIMADZU mass spectrometer using chemical ionization technique. 
 
2.2. Preparation of hydroxyapatite 
Hydroxyapatite catalyst was prepared by aqueous precipitation 
method reported in literature [33].   Suspension (10 cm3) of 0.5M calcium 
hydroxide was prepared from calcium hydroxide powder.  The degased 
suspension was stirred vigorously and heated at 40°C for 2h. About 
10 cm3 of phosphoric acid solution (0.3 M) was added drop-wise to it and 
kept aside an hour.  The pH of the solution was adjusted to 9.5 by adding 
ammonium hydroxide solution. The mixture was stirred using magnetic 
stirrer for 2h at the speed of 25 rpm, aged for 24 h in room and 
centrifuged to completion of precipitation. The precipitate was dried at 
100°C for 12h.  The obtained calcium hydroxyapatite catalyst have 
1.8 Ca/P ratio was kept in vacuum desiccator. 
 
2.3. Preparation of chalcones 
The aryl chalcones were prepared according to literature procedure 
[31]. An appropriate equimolar quantities of aryl methyl ketones 
(2 mmol), various substituted benzaldehydes (2 mmol) in methanol 
(10 cm3) and 1 g hydroxyapatite was added and the mixture was stirred at 
room temperature for 5 min. Methanol was evaporated to give  
a homogeneous solid. About 5 cm3 of water was added to this solid and 
the mixture was irradiated by microwave for the appropriate time. After 
completion of reaction, dichloromethane (20 cm3) was added, followed by 
simple filtration. The solution was concentrated and to purified by re-
crystallization. The purities of synthesized chalcones were examined by 
their physical constants, IR, 1H and 13C NMR and Mass spectral data 
reported in literature[31]. 
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2.4. Synthesis of 4-(aryl)-5,6-dihydro-6-(substituted phenyl)-4H-1,3-oxa- 
       zine-2-amines 
An appropriate equi-molar quantities of chalcones (2 mmol), 
urea (2 mmol) and 0.2 g of hydroxyapatite were taken in a 50 cm3 beaker, 
closed with the lid. This mixture was subjected to microwave irradiation 
for 2-4 minutes at 650W (Scheme 1) (Samsung, Microwave Oven,  
100-700W). After completion of the reaction, dichloromethane (20 cm3) 
was added, followed by simple filtration. The solution was concentrated 
and purified by re-crystallization. The synthesized oxazines were 
characterized by their physical constants, and mass fragments were 
presented in Table 1.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Synthesis of 4-aryl-5,6-dihydro-6-(substituted phenyl)-4H-1,3-oxazi- 
                ne-2-amines hydroxyapatite catalyzed cyclization of aryl chalcones  
                and urea under microwave irradiation. 
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Table 2. The effect of solvents in conventional heating and without sol- 
               vent in microwave irradiation on yield of 4-(4-Methyl-1-naphthyl)- 
               5,6-dihydro-6-phenyl-4H-1,3-oxazine-2-amine (entry 11). 
Solvents 
Microwave irradiation 
MeOH EtOH DCM THF 
61 60 64 65 90 
MeOH = Methanol; EtOH = Ethanol; DCM = Dihloromethane; 
THF = Tetrahydrofuron. 
 
 
3. RESULTS AND DISCUSSION 
 
The author attempts made to synthesize   some 4-aryl-5,6-dihydro-
6(substituted phenyl)-4H-1,3-oxazine-2-amine derivatives by cyclization 
of chalcones possess   electron with-drawing  as well as electron donating  
group as substituents, urea and  in the presence of a catalyst hydroxyl-
apatite
 
using  microwave irradiation. Hence the authors have synthesized  
some 4-aryl-5,6-dihydro-6(substituted phenyl)-4H-1,3-oxazine-2-amine 
derivatives by the cyclization of  2 mmole of chalcone,  2 mmole  of urea  
under  microwave irradiation with  0.2 g  of hydroxyapatite
 
catalyst at  
550W for 4-6 minutes (Samsung Grill, GW73BD Microwave oven, 230V 
A/c, 50Hz, 2450Hz, 100-750W (IEC-705), (Scheme 1). During the course 
of this reaction hydroxyapatite
 
catalyses cyclization between chalcones 
and urea followed by rearrangement gave the 1, 3-oxazine amines. The 
yield of the oxazine in this reaction is more than 80 %. The chalcone 
containing electron donating substituent (OCH3) gave higher yields than 
electron-withdrawing (halogens, NO2) substituents. Further we have 
investigated this cyclization reaction with equimolar quantities of the 
styryl 4-methyl-1-naphthyl ketone (entry 11) and urea under the same 
condition as above.  In this reaction the obtained yield was 90 %.  The 
effect of catalyst on this reaction was studied by varying the catalyst 
quantity from 0.05  to 0.2 g.  As the catalyst quantity is increased from 
0.05 to 0.2 g, the percentage of yield of product is increased from 84 to 
90%.  About 1% product was obtained increased by increasing the 
amount of catalyst 0.5 g. About 3% of product was obtained by increasing 
0.15 g  of catalyst. About 6% of product were obtained for increasing the 
amount of catalyst  0.2 g. Further increase in the catalyst amount beyond 
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0.2 g, there is no significant increase in the percentage of the product. The 
effect of catalyst loading is shown in Fig. 1.  
 
Fig. 1. Effect of catalyst loading. 
 
The optimum quantity of catalyst loading was found to be 0.2 g.  The 
results, analytical and mass spectral data are summarized in Table 1. The 
effect of solvents on the yield was also studied with methanol, ethanol, 
dichloromethane and tetrahydrofuran from each component of the catalyst 
(entry 11). Similarly the effect of microwave irradiation was studied on 
each component of the catalyst.  The effect of solvents on the yield of 
oxazine derivatives was presented in Table 2. From the table highest yield 
of oxazine obtained from the cyclization of chalcones and urea  with the 
catalyst hydroxyapatite
 
in microwave irradiation. The infrared and nmr 
spectroscopic data of selective oxazine-2-amine derivatives are 
summarized below.  
 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-phenyl-4H-1,3-oxazine-2-amine (11): 
FTIR(KBr): 353834(NH), 1591(C=N), 1216(C-O-C) cm–1. 1H NMR (CDCl3-d6, 
TMS)?: 2.331(s, 1H, NH2), 2.625(dd, 1H, H4), 2.415(dd, 1H, H5), 2.219(dd, 1H, 
H5?), 4.232(dd, 1H, H6), 4.572 (s, 3H, OCH3), 6.511-7.338(m, 11H, Ar-H) ppm.; 
13C NMR (CDCl3-d6, TMS)?: 165.45(C2), 52.72 (C4),  47.38 (C5), 65.64 (C6), 
57.23(OCH3), 125.33-142.79(Ar-C)ppm. 
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4-(4-Mthyl-1-naphthyl)-5,6-dihydro-6-(3-aminoyphenyl)-4H-1,3-oxazine-2-ami-
ne (12): FTIR(KBr): 3560(NH), 1615(C=N), 1224(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.231 (s, 1H, NH2), 2.528 (dd, 1H, H4), 2.458(dd, 1H, H5), 
2.233 (dd, 1H, H5?), 4.358 (dd, 1H, H6), 3.238 (s, 3H, CH3), 6.282-7.254(m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.38(C2), 51.09 (C4),  47.79 (C5), 
66.31 (C6),   28.12(CH3), 126.26-139.29 (Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-aminophenyl)-4H-1,3-oxazine-2-ami-
ne (13): FTIR(KBr): 3550(NH), 1615(C=N), 1226(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.225 (s, 1H, NH2), 2.532 (dd, 1H, H4), 2.469(dd, 1H, H5), 
2.246 (dd, 1H, H5?), 4.378(dd, 1H, H6), 3.228(s, 3H, CH3), 6.277-7.239 (m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.76(C2), 51.49 (C4),  47.61(C5), 
66.90 (C6),   27.14(CH3), 126.38-139.37 (Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(3-bromophenyl)-4H-1,3-oxazine-2-ami-
ne (14): FTIR(KBr): 3546(NH), 1622(C=N), 1219(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.217 (s, 1H, NH2), 2.323(dd, 1H, H4), 2.224 (dd, 1H, H5), 
2.231 (dd, 1H, H5?), 4.340(dd, 1H, H6), 3.379 (s, 3H, OCH3), 6.243-7.290 (m, 
10H, Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.49 (C2), 51.80 (C4),  
47.30(C5), 66.67 (C6),   25.32(CH3), 124.37-139.30 (Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(3-chlorophenyl)-4H-1,3-oxazine-2-ami-
ne (15): FTIR(KBr): 3545(NH), 1613(C=N), 1222(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.267 (s, 1H, NH2), 2.329 (dd, 1H, H4), 2.421(dd, 1H, H5), 
2.256 (dd, 1H, H5?), 4.329(dd, 1H, H6), 3.247 (s, 3H, CH3), 6.249-7.290 (m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.98(C2), 51.78 (C4),  47.09(C5), 
66.36 (C6),   21.23(CH3), 126.45-139.78 (Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-chlorophenyl)-4H-1,3-oxazine-2-ami-
ne (16): FTIR(KBr): 3555(NH), 1615(C=N), 1230(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.220 (s, 1H, NH2), 2.319 (dd, 1H, H4), 2.418(dd, 1H, H5), 
2.229(dd, 1H, H5?), 4.367(dd, 1H, H6), 3.232(s, 3H, CH3), 6.219-7.252 (m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.23(C2), 51.22 (C4),  47.43(C5), 
66.78 (C6),   25.19(CH3), 126.26-139.67(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-dimethylaminophenyl)-4H-1,3-oxa-
zine-2-amine (17): FTIR(KBr): 3530(NH), 1602(C=N), 1216(C-O-C) cm–1. 1H 
NMR (CDCl3-d6, TMS)?: 2.217 (s, 1H, NH2), 2.332 (dd, 1H, H4), 2.424(dd, 1H, 
H5), 2.232(dd, 1H, H5?), 4.332(dd, 1H, H6), 3.645(s, 6H, N(CH3)2), 3.233(s, 3H, 
CH3), 26.234-7.278 (m, 10H, Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.89 
(C2), 51.58 (C4),  47.87(C5), 66.67 (C6),   44.89(N(CH3)2), 24.56(CH3), 126.22-
139.10(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-hydroxyphenyl)-4H-1,3-oxazine-2-
amine (18): FTIR(KBr): 3545(NH), 1611(C=N), 1212(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.217 (s, 1H, NH2), 2.343 (dd, 1H, H4), 2.476(dd, 1H, H5), 
2.233(dd, 1H, H5?), 4.358(dd, 1H, H6), 3.268(s, 3H, CH3), 6.246-7.276(m, 10H, 
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Ar-H) ppm. 13C NMR (CDCl3-d6, TMS)?: 164.6734 (C2), 51.98 (C4), 47.36(C5), 
63.58 (C6), 44.12 (N(CH3)2), 24.26(s, 3H, CH3), 126.65-139.98(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-methoxyphenyl)-4H-1,3-oxazine-2-
amine (19): FTIR(KBr): 3545(NH), 1623(C=N), 1210(C-O-C) cm-1. 1H NMR 
(CDCl3-d6, TMS)?: 2.214 (s, 1H, NH2), 2.324(dd, 1H, H4), 2.437(dd, 1H, H5), 
2.219(dd, 1H, H5?), 4.366(dd, 1H, H6), 4.234 (s, 3H, OCH3), 3.657(s, 3H, CH3), 
6.267-7.289(m, 10H, Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.57 (C2), 
51.67 (C4),  47.34(C5), 66.01 (C6),   64.34(s, 3H, OCH3), 24.64(s, 3H, CH3), 
126.34-139.76(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-methylphenyl)-4H-1,3-oxazine-2-ami-
ne (20): FTIR(KBr): 3535(NH), 1612(C=N), 1211(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.215 (s, 1H, NH2), 2.327 (dd, 1H, H4), 2.433(dd, 1H, H5), 
2.223(dd, 1H, H5?), 4.346(dd, 1H, H6), 2.733 (s, 3H, CH3), 4.213 (s, 3H, OCH3), 
6.223-7.216(m, 10H, Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.26 (C2), 
51.29 (C4),  47.43C5), 66.32 (C6),  26.35(CH3), 64.66(OCH3), 114.33-145.26(Ar-
C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(2-nitrophenyl)-4H-1,3-oxazine-2-ami-
ne (21): FTIR(KBr): 3556(NH), 1625(C=N), 1214(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.218 (s, 1H, NH2), 2.335 (dd, 1H, H4), 2.446(dd, 1H, H5), 
2.227(dd, 1H, H5?), 4.348(dd, 1H, H6), 3.268 (s, 3H, CH3), 6.233-7.267(m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 64.90(C2), 51.31 (C4),  47.34(C5), 
66.76 (C6),   27.87(s, 3H, CH3), 114.45-145.67(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(3-nitrophenyl)-4H-1,3-oxazine-2-ami-
ne (22): FTIR(KBr): 3555(NH), 1618(C=N), 1223(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.215 (s, 1H, NH2), 2.338(dd, 1H, H4), 2.460(dd, 1H, H5), 
2.234(dd, 1H, H5?), 4.365(dd, 1H, H6), 3.356 (s, 3H, CH3), 6.546-7.289(m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.78(C2), 51.34 (C4),  47.42(C5), 
66.67 (C6),   24.67(s, 3H, CH3), 124.98-145.47(Ar-C)ppm. 
4-(4-Methyl-1-naphthyl)-5,6-dihydro-6-(4-nitrophenyl)-4H-1,3-oxazine-2-ami-
ne (23): FTIR(KBr): 3550(NH), 1625(C=N), 1230(C-O-C) cm–1. 1H NMR 
(CDCl3-d6, TMS)?: 2.215 (s, 1H, NH2), 2.333(dd, 1H, H4), 2.454(dd, 1H, H5), 
2.236(dd, 1H, H5?), 4.343(dd, 1H, H6), 3.223 (s, 3H, CH3), 6.534-7.234(m, 10H, 
Ar-H) ppm.  13C NMR (CDCl3-d6, TMS)?: 164.34(C2), 51.65 (C4),  47.37(C5), 
66.56 (C6),  24.64(s, 3H, CH3), 124.46-145.43(Ar-C)ppm. 
 
 
4. CONCLUSIONS 
 
Some unsaturated 4-aryl-5,6-dihydro-6(substituted phenyl)-4H-1,3-
oxazine-2-amines derivatives including 4-(4-methyl-1-naphthyl)-5,6-
dihydro-6-(substituted phenyl)-oxazine-2-amines have been  synthesised 
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by solvent-free cyclization of aryl chalcones and urea in presence of 
hydroxy apatite
 
catalyst under microwave irradiation.  The yields of these 
oxazines were more than 85%. This synthetic methodology offers non-
hazardous, solvent-free cyclization, easy-workup procedure, shorter 
reaction time and better yields. These oxazine derivatives were 
characterized by their physical constants, spectral data and these data 
supports the compounds.   
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